Holen Sie sich die Stockscreener-App
0.00
100.00%
-90.00
Handel nachbörslich:
88.97
88.97
+
Schlusskurs vom Vortag:
$90.00
Offen:
$0
24-Stunden-Volumen:
0
Relative Volume:
0.00
Marktkapitalisierung:
$6.83B
Einnahmen:
$35.93M
Nettoeinkommen (Verlust:
$-244.56M
KGV:
0.00
EPS:
-3.95
Netto-Cashflow:
$-157.31M
1W Leistung:
-100.00%
1M Leistung:
-100.00%
6M Leistung:
-100.00%
1J Leistung:
-100.00%
1-Tages-Spanne:
$0.00
$0.00
1-Wochen-Bereich:
$0.00
$0.00
52-Wochen-Spanne:
$0.00
$97.14
Merus N V Stock (MRUS) Company Profile
Firmenname
Merus N V
Sektor
Branche
Telefon
31 030 253 8800
Adresse
YALELAAN 62, 3584 CM UTRECHT
Vergleichen Sie MRUS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MRUS
Merus N V
|
0.00 | 6.83B | 35.93M | -244.56M | -157.31M | -3.95 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.38 | 113.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.54 | 80.22B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
406.40 | 52.56B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
803.74 | 49.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.07 | 37.37B | 447.02M | -1.18B | -906.14M | -6.1812 |
Merus N V Stock (MRUS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-17 | Eingeleitet | Barclays | Overweight |
| 2025-08-25 | Eingeleitet | Alliance Global Partners | Buy |
| 2025-02-13 | Eingeleitet | Piper Sandler | Overweight |
| 2025-02-07 | Eingeleitet | Wells Fargo | Overweight |
| 2024-11-21 | Eingeleitet | Goldman | Buy |
| 2024-10-24 | Eingeleitet | UBS | Buy |
| 2024-03-28 | Eingeleitet | Truist | Buy |
| 2024-03-04 | Bestätigt | Needham | Buy |
| 2023-11-02 | Eingeleitet | Canaccord Genuity | Buy |
| 2023-08-21 | Eingeleitet | TD Cowen | Outperform |
| 2022-08-02 | Eingeleitet | Stifel | Buy |
| 2022-02-11 | Eingeleitet | BMO Capital Markets | Outperform |
| 2022-02-10 | Eingeleitet | Needham | Buy |
| 2021-11-17 | Fortgesetzt | Guggenheim | Buy |
| 2021-06-07 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-04-08 | Eingeleitet | William Blair | Outperform |
| 2021-03-16 | Eingeleitet | SVB Leerink | Outperform |
| 2020-06-26 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-05-27 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2019-11-20 | Fortgesetzt | Guggenheim | Buy |
| 2019-06-28 | Eingeleitet | ROTH Capital | Buy |
| 2019-04-12 | Fortgesetzt | Guggenheim | Buy |
| 2019-04-03 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2019-03-27 | Eingeleitet | Berenberg | Buy |
| 2018-01-02 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2017-09-15 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2017-03-21 | Herabstufung | Citigroup | Buy → Neutral |
| 2016-12-22 | Hochstufung | Citigroup | Neutral → Buy |
| 2016-11-07 | Herabstufung | Citigroup | Buy → Neutral |
| 2016-06-13 | Eingeleitet | Citigroup | Buy |
| 2016-06-13 | Eingeleitet | Guggenheim | Buy |
| 2016-06-13 | Eingeleitet | Wedbush | Outperform |
Alle ansehen
Merus N V Aktie (MRUS) Neueste Nachrichten
Merus N.V. (MRUS) Stock Analysis: Exploring a 7.78% Potential Upside Amid Biotech Innovations - DirectorsTalk Interviews
Genmab Announces $2.5 Billion Note Offering for Merus Acquisition - MSN
What analysts say about Merus NV stockTrading Volume Surges & Outstanding Investment Returns - earlytimes.in
Retail Trends: How Merus NV 2GH stock moves in volatile trading sessionsProduct Launch & Free Expert Verified Stock Movement Alerts - moha.gov.vn
Why retail investors favor Merus N.V. stockEconomic Indicators Overview & Low Risk Capital Growth Plans - bollywoodhelpline.com
Moody Aldrich Partners LLC Reduces Position in Merus N.V. $MRUS - MarketBeat
Genmab stock slides today as GMAB shelves acasunlimab; Merus takeout steps in focus - ts2.tech
Insider Buying: Merus (NASDAQ:MRUS) Major Shareholder Acquires 2,978 Shares of Stock - MarketBeat
Merus stock halted today as Genmab buyout closes: what happens to MRUS shares and the $97 cash payout - ts2.tech
Genmab completes acquisition of Merus and delists shares from Nasdaq By Investing.com - Investing.com Australia
Merus Completes Genmab Acquisition and Delists From Nasdaq - TipRanks
Genmab completes acquisition of Merus and delists shares from Nasdaq - Investing.com
Merus Announced Transfer or Voluntary Withdrawal of Listing - TradingView — Track All Markets
Simplify Asset Management Inc. Takes $3.14 Million Position in Merus N.V. $MRUS - MarketBeat
Merus (NASDAQ:MRUS) Major Shareholder A/S Genmab Acquires 96,082 Shares - MarketBeat
Insider Buying: Merus (NASDAQ:MRUS) Major Shareholder Acquires 142,610 Shares of Stock - MarketBeat
A/S Genmab Purchases 561,042 Shares of Merus (NASDAQ:MRUS) Stock - MarketBeat
Insider Buying: Merus (NASDAQ:MRUS) Major Shareholder Purchases 15,710 Shares of Stock - MarketBeat
Merus (NASDAQ:MRUS) Stock Price Down 7%Here's Why - MarketBeat
Fed Watch: Why Merus NV 2GH stock stays undervaluedLong Setup & Weekly Breakout Watchlists - moha.gov.vn
Merus N.V. (NASDAQ:MRUS) Sees Large Decrease in Short Interest - MarketBeat
Stock Traders Buy High Volume of Call Options on Merus (NASDAQ:MRUS) - MarketBeat
Harbor Capital Advisors Inc. Trims Stock Holdings in Merus N.V. $MRUS - MarketBeat
Revenue per share of Merus N.V. – FWB:2GH - TradingView — Track All Markets
GENMAB AS Insider Trades - Nasdaq
A/S Genmab Acquires 66,264 Shares of Merus (NASDAQ:MRUS) Stock - MarketBeat
Merus N.V. $MRUS Stock Position Decreased by Voya Investment Management LLC - MarketBeat
A/S Genmab Acquires 212,177 Shares of Merus (NASDAQ:MRUS) Stock - MarketBeat
How Merus N.v. (MRUS) Affects Rotational Strategy Timing - Stock Traders Daily
MRUS SEC FilingsMerus 10-K, 10-Q, 8-K Forms - Stock Titan
Will Merus N.V. stock maintain dividend yieldJuly 2025 Volume & Verified Stock Trade Ideas - Улправда
Is Merus N.V. (2GH) stock positioned for digital growth eraMarket Performance Summary & Stepwise Swing Trade Plans - Улправда
Will Merus N.V. stock maintain momentum in 2025Weekly Profit Summary & Stock Portfolio Risk Control - Улправда
How Merus N.V. (2GH) stock stacks up against competitorsQuarterly Earnings Report & Free Community Consensus Stock Picks - Улправда
How Merus N.V. (2GH) stock trades in high volatilityPrice Action & Advanced Technical Analysis Signals - DonanımHaber
How cyclical is Merus N.V. (2GH) stock compared to rivalsJuly 2025 Update & Advanced Swing Trade Entry Alerts - Улправда
Insider Buying: Merus (NASDAQ:MRUS) Major Shareholder Buys 150,795 Shares of Stock - MarketBeat
Owner Genmab A/S Buys 271,547 ($26.3M) Of Merus NV [MRUS] - TradingView — Track All Markets
Genmab (GMAB) reports 94.2% ownership of Merus at $97 per share - Stock Titan
A/S Genmab Purchases 120,752 Shares of Merus (NASDAQ:MRUS) Stock - MarketBeat
Sanders Morris Harris LLC Buys Shares of 24,870 Merus N.V. $MRUS - MarketBeat
Merus N.V.(NasdaqGM: MRUS) dropped from S&P Global BMI Index - marketscreener.com
Merus (NASDAQ:MRUS) Sets New 12-Month HighShould You Buy? - MarketBeat
Merus NV stock hits all-time high at 96.95 USD By Investing.com - Investing.com South Africa
Merus NV stock hits all-time high at 96.95 USD - Investing.com
Immunotherapy Breakthroughs Turn Cold GI Tumors Hot as Market Tops $443B - Benzinga
Revenue per share of Merus N.V. – LSX:A2AKFX - TradingView — Track All Markets
Merus acquired by Genmab, leadership changes announced - MSN
Holocene Advisors LP Boosts Position in Merus N.V. $MRUS - MarketBeat
Boothbay Fund Management LLC Grows Holdings in Merus N.V. $MRUS - MarketBeat
Merus N.V. (NASDAQ:MRUS) Given Consensus Rating of "Hold" by Brokerages - MarketBeat
Finanzdaten der Merus N V-Aktie (MRUS)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.52%
0.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):